A new study from King’s College London has found that most people who take selective serotonin reuptake inhibitors (SSRIs), a ...

A new study has found that adults with depression who start treatment with newer antipsychotic medications may face a higher ...

Despite claims that antidepressants may be just delivering a placebo effect, three-quarters of people who tried them in a ...

Johnson & Johnson will stop late-stage studies of its experimental drug to treat major depressive disorder due to a lack of ...

It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...

An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.

Researchers are conducting a clinical trial to evaluate RE104, a novel psychedelic drug similar to 'magic mushrooms,' as a ...

“Abrupt” reductions in antidepressant treatment “ranging from 20 percent to 50 percent” Increases in psychotropic drug ...

Analysts say the decision is a “big blow” to a once-promising class of brain therapies that include’s J&J’s aticaprant and a ...